The identification of hub genes displaying differential expression levels in relation to Tim-3 may offer valuable opportunities to deepen our understanding of prognosis and the role of LSCs within the Tumor Immune Microenvironment (TME) of AML. This evidence concerns the gene HAVCR2 and neoplasm.